Update on Sepsis Epidemiology in the Era of COVID-19

 

 Buy Article Permissions and Reprints

Abstract

Timely and accurate data on the epidemiology of sepsis is essential to inform public policy, clinical practice, and research priorities. Recent studies have illuminated several ongoing questions about sepsis epidemiology, including the incidence and outcomes of sepsis in non-Western countries and in specialized populations such as surgical patients, patients with cancer, and the elderly. There have also been new insights into the limitations of current surveillance methods using administrative data and increasing experience tracking sepsis incidence and outcomes using “big data” approaches that take advantage of detailed electronic health record data. The COVID-19 pandemic, however, has fundamentally changed the landscape of sepsis epidemiology. It has increased sepsis rates, helped highlight ongoing controversies about how to define sepsis, and intensified debate about the possible unintended consequences of overly rigid sepsis care bundles. Despite these controversies, there is a growing consensus that severe COVID-19 causing organ dysfunction is appropriate to label as sepsis, even though it is treated very differently from bacterial sepsis, and that surveillance strategies need to be modified to reliably identify these cases to fully capture and delineate the current burden of sepsis. This review will summarize recent insights into the epidemiology of sepsis and highlight several urgent questions and priorities catalyzed by COVID-19.

Publication History

Article published online:
16 January 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Shappell CN, Klompas M, Rhee C. Surveillance strategies for tracking sepsis incidence and outcomes. J Infect Dis 2020; 222 (Suppl. 02) S74-S83
  CrossrefPubMedGoogle Scholar
• 2 Liu V, Escobar GJ, Greene JD. et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014; 312 (01) 90-92
  CrossrefPubMedGoogle Scholar
• 3 Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by payer, 2013: Statistical Brief #204. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: 2006
  Google Scholar
• 4 Rudd KE, Johnson SC, Agesa KM. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395 (10219): 200-211
  CrossrefPubMedGoogle Scholar
• 5 Rhee C, Dantes R, Epstein L. et al; CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA 2017; 318 (13) 1241-1249
  CrossrefPubMedGoogle Scholar
• 6 Rhodes A, Evans LE, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43 (03) 304-377
  CrossrefPubMedGoogle Scholar
• 7 Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med 2018; 46 (06) 997-1000
  CrossrefPubMedGoogle Scholar
• 8 Barbash IJ, Davis B, Kahn JM. National performance on the Medicare SEP-1 sepsis quality measure. Crit Care Med 2019; 47 (08) 1026-1032
  CrossrefPubMedGoogle Scholar
• 9 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
  Google Scholar
• 10 Rhee C, Kadri SS, Danner RL. et al. Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care 2016; 20: 89
  CrossrefPubMedGoogle Scholar
• 11 Angus DC, Seymour CW, Coopersmith CM. et al. A framework for the development and interpretation of different sepsis definitions and clinical criteria. Crit Care Med 2016; 44 (03) e113-e121
  CrossrefPubMedGoogle Scholar
• 12 Vincent JL. COVID-19: it's all about sepsis. Future Microbiol 2021; 16: 131-133
  CrossrefPubMedGoogle Scholar
• 13 Boncyk CS, Mart MF, Ely EW. Does COVID-19 Cause Sepsis? Medscape Critical Care. 2020. Accessed November 11, 2020 at: https://www.medscape.com/viewarticle/939038. Published October 16, 2020
  PubMedGoogle Scholar
• 14 Shappell CN, Klompas M, Rhee C. Does severe acute respiratory syndrome coronavirus 2 cause sepsis?. Crit Care Med 2020; 48 (12) 1707-1709
  CrossrefPubMedGoogle Scholar
• 15 European Society of Intensive Care Medicine (ESICM), Global Sepsis Alliance (GSA), Society of Critical Care Medicine (SCCM). Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?. Intensive Care Med 2021; 47 (07) 733-736
  CrossrefPubMedGoogle Scholar
• 16 Bilinski A, Emanuel EJ. COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA 2020; 324 (20) 2100-2102
  CrossrefPubMedGoogle Scholar
• 17 Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, March-April 2020. JAMA 2020; 324 (05) 510-513
  CrossrefPubMedGoogle Scholar
• 18 Klompas M, Rhee C. Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick. Crit Care 2016; 20 (01) 396
  CrossrefPubMedGoogle Scholar
• 19 Klompas M, Rhee C. We need better tools for sepsis surveillance. Crit Care Med 2016; 44 (07) 1441-1442
  CrossrefPubMedGoogle Scholar
• 20 Chou EH, Mann S, Hsu TC. et al. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: a nationwide study. PLoS One 2020; 15 (01) e0227752
  CrossrefPubMedGoogle Scholar
• 21 Wardi G, Tainter CR, Ramnath VR. et al. Age-related incidence and outcomes of sepsis in California, 2008-2015. J Crit Care 2021; 62: 212-217
  CrossrefPubMedGoogle Scholar
• 22 Te Marvelde L, Whitfield A, Shepheard J, Read C, Milne RL, Whitfield K. Epidemiology of sepsis in cancer patients in Victoria, Australia: a population-based study using linked data. Aust N Z J Public Health 2020; 44 (01) 53-58
  CrossrefPubMedGoogle Scholar
• 23 Oh SY, Cho S, Kim GH. et al. Incidence and outcomes of sepsis in Korea: a nationwide cohort study from 2007 to 2016. Crit Care Med 2019; 47 (12) e993-e998
  CrossrefPubMedGoogle Scholar
• 24 Chen YJ, Chen FL, Chen JH. et al. Epidemiology of sepsis in Taiwan. Medicine (Baltimore) 2019; 98 (20) e15725
  CrossrefPubMedGoogle Scholar
• 25 Madenci AL, Armstrong LB, Kwon NK. et al. Incidence and risk factors for sepsis after childhood splenectomy. J Pediatr Surg 2019; 54 (07) 1445-1448
  CrossrefPubMedGoogle Scholar
• 26 Yu CW, Chang SS, Lai CC. et al. Epidemiology of emergency department sepsis: a national cohort study between 2001 and 2012. Shock 2019; 51 (05) 619-624
  CrossrefPubMedGoogle Scholar
• 27 Patel N, Bajaj NS, Doshi R. et al. Cardiovascular events and hospital deaths among patients with severe sepsis. Am J Cardiol 2019; 123 (09) 1406-1413
  CrossrefPubMedGoogle Scholar
• 28 Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35 (05) 1244-1250
  CrossrefPubMedGoogle Scholar
• 29 Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348 (16) 1546-1554
  CrossrefPubMedGoogle Scholar
• 30 Kumar G, Kumar N, Taneja A. et al; Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011; 140 (05) 1223-1231
  CrossrefPubMedGoogle Scholar
• 31 Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012; 40 (03) 754-761
  CrossrefPubMedGoogle Scholar
• 32 Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013; 41 (05) 1167-1174
  CrossrefPubMedGoogle Scholar
• 33 Rubens M, Saxena A, Ramamoorthy V. et al. Increasing sepsis rates in the United States: results from national inpatient sample, 2005 to 2014. J Intensive Care Med 2020; 35 (09) 858-868
  CrossrefPubMedGoogle Scholar
• 34 Pertsch NJ, Tang OY, Seicean A, Toms SA, Weil RJ. Sepsis after elective neurosurgery: incidence, outcomes, and predictive factors. J Clin Neurosci 2020; 78: 53-59
  CrossrefPubMedGoogle Scholar
• 35 Xie J, Wang H, Kang Y. et al; CHinese Epidemiological Study of Sepsis (CHESS) Study Investigators. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med 2020; 48 (03) e209-e218
  CrossrefPubMedGoogle Scholar
• 36 Tian HC, Zhou JF, Weng L. et al; For China Critical Care Clinical Trials Group (CCCCTG). Epidemiology of Sepsis-3 in a sub-district of Beijing: secondary analysis of a population-based database. Chin Med J (Engl) 2019; 132 (17) 2039-2045
  CrossrefPubMedGoogle Scholar
• 37 Dong R, Tian H, Zhou J. et al; China Critical Care Clinical Trials Group (CCCCTG). External validity of Adult Sepsis Event's simplified eSOFA criteria: a retrospective analysis of patients with confirmed infection in China. Ann Intensive Care 2020; 10 (01) 14
  CrossrefPubMedGoogle Scholar
• 38 Rhee C, Jones TM, Hamad Y. et al; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open 2019; 2 (02) e187571
  CrossrefPubMedGoogle Scholar
• 39 Rhee C, Brown SR, Jones TM. et al; CDC Prevention Epicenters Program. Variability in determining sepsis time zero and bundle compliance rates for the centers for Medicare and Medicaid services SEP-1 measure. Infect Control Hosp Epidemiol 2018; 39 (08) 994-996
  CrossrefPubMedGoogle Scholar
• 40 Cooper AJ, Keller SP, Chan C. et al. Improvements in sepsis-associated mortality in hospitalized patients with cancer versus those without cancer. A 12-year analysis using clinical data. Ann Am Thorac Soc 2020; 17 (04) 466-473
  CrossrefPubMedGoogle Scholar
• 41 Rhee C, Wang R, Zhang Z, Fram D, Kadri SS, Klompas M. CDC Prevention Epicenters Program. Epidemiology of hospital-onset versus community-onset sepsis in U.S. hospitals and association with mortality: a retrospective analysis using electronic clinical data. Crit Care Med 2019; 47 (09) 1169-1176
  CrossrefPubMedGoogle Scholar
• 42 Wayne MT, Molling D, Wang XQ. et al. Measurement of sepsis in a national cohort using three different methods to define baseline organ function. Ann Am Thorac Soc 2021; 18 (04) 648-655
  CrossrefPubMedGoogle Scholar
• 43 Rhee C, Zhang Z, Kadri SS. et al; CDC Prevention Epicenters Program. Sepsis surveillance using adult sepsis events simplified eSOFA criteria versus Sepsis-3 sequential organ failure assessment criteria. Crit Care Med 2019; 47 (03) 307-314
  CrossrefPubMedGoogle Scholar
• 44 Valik JK, Ward L, Tanushi H. et al. Validation of automated sepsis surveillance based on the Sepsis-3 clinical criteria against physician record review in a general hospital population: observational study using electronic health records data. BMJ Qual Saf 2020; 29 (09) 735-745
  CrossrefPubMedGoogle Scholar
• 45 Liu YZ, Chu R, Lee A. et al. A surveillance method to identify patients with sepsis from electronic health records in Hong Kong: a single centre retrospective study. BMC Infect Dis 2020; 20 (01) 652
  CrossrefPubMedGoogle Scholar
• 46 Valik JK, Mellhammar L, Sundén-Cullberg J. et al. Peripheral oxygen saturation facilitates assessment of respiratory dysfunction in the sequential organ failure assessment score with implications for the Sepsis-3 criteria. Crit Care Med 2022; 50 (03) e272-e283
  CrossrefPubMedGoogle Scholar
• 47 Shappell CN, Rhee C. Leveraging electronic health record data to improve sepsis surveillance. BMJ Qual Saf 2020; 29 (09) 706-710
  CrossrefPubMedGoogle Scholar
• 48 Rhee C, Klompas M. Conducting sepsis surveillance by applying Sepsis-3 criteria to electronic health record data: promises and potential pitfalls. Crit Care Med 2021; 49 (11) 1983-1986
  CrossrefPubMedGoogle Scholar
• 49 Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29 (07) 1303-1310
  CrossrefPubMedGoogle Scholar
• 50 Churpek MM, Dumanian J, Dussault N. et al. Determining the electronic signature of infection in electronic health record data. Crit Care Med 2021; 49 (07) e673-e682
  CrossrefPubMedGoogle Scholar
• 51 Seymour CW, Liu VX, Iwashyna TJ. et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 762-774
  CrossrefPubMedGoogle Scholar
• 52 Plaeke P, De Man JG, Coenen S, Jorens PG, De Winter BY, Hubens G. Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients. Surg Today 2020; 50 (05) 427-439
  CrossrefPubMedGoogle Scholar
• 53 Zhou J, Luo XY, Chen GQ. et al. Incidence, risk factors and outcomes of sepsis in critically ill post-craniotomy patients: a single-center prospective cohort study. Front Public Health 2022; 10: 895991
  CrossrefPubMedGoogle Scholar
• 54 Howitt SH, Herring M, Malagon I, McCollum CN, Grant SW. Incidence and outcomes of sepsis after cardiac surgery as defined by the Sepsis-3 guidelines. Br J Anaesth 2018; 120 (03) 509-516
  CrossrefPubMedGoogle Scholar
• 55 Wu MC, Tsou HK, Lin CL, Wei JC. Incidence and risk of sepsis following appendectomy: a nationwide population-based cohort study. Sci Rep 2020; 10 (01) 10171
  CrossrefPubMedGoogle Scholar
• 56 Hensley MK, Donnelly JP, Carlton EF, Prescott HC. Epidemiology and outcomes of cancer-related versus non-cancer-related sepsis hospitalizations. Crit Care Med 2019; 47 (10) 1310-1316
  CrossrefPubMedGoogle Scholar
• 57 Liu MA, Bakow BR, Hsu TC. et al. Temporal trends in sepsis incidence and mortality in patients with cancer in the US population. Am J Crit Care 2021; 30 (04) e71-e79
  CrossrefPubMedGoogle Scholar
• 58 Kim YJ, Kim MJ, Kim YJ, Kim WY. Short and long-term mortality trends for cancer patients with septic shock stratified by cancer type from 2009 to 2017: a population-based cohort study. Cancers (Basel) 2021; 13 (04) 657
  CrossrefPubMedGoogle Scholar
• 59 Girard TD, Opal SM, Ely EW. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis 2005; 40 (05) 719-727
  CrossrefPubMedGoogle Scholar
• 60 Buchman TG, Simpson SQ, Sciarretta KL. et al. Sepsis among Medicare beneficiaries: 1. The burdens of sepsis, 2012-2018. Crit Care Med 2020; 48 (03) 276-288
  CrossrefPubMedGoogle Scholar
• 61 Rhee C, Klompas M. The eye-popping costs associated with sepsis diagnoses among Medicare beneficiaries. Crit Care Med 2020; 48 (03) 420-422
  CrossrefPubMedGoogle Scholar
• 62 Lee SH, Hsu TC, Lee MG. et al; National Taiwan University Health Economics and Outcome Research Group. Nationwide trend of sepsis: a comparison among octogenarians, elderly, and young adults. Crit Care Med 2018; 46 (06) 926-934
  CrossrefPubMedGoogle Scholar
• 63 Quintano Neira RA, Hamacher S, Japiassú AM. Epidemiology of sepsis in Brazil: incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015. PLoS One 2018; 13 (04) e0195873
  CrossrefPubMedGoogle Scholar
• 64 Ljungström L, Andersson R, Jacobsson G. Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden - a prospective population-based study. PLoS One 2019; 14 (12) e0225700
  CrossrefPubMedGoogle Scholar
• 65 Fay K, Sapiano MRP, Gokhale R. et al. Assessment of health care exposures and outcomes in adult patients with sepsis and septic shock. JAMA Netw Open 2020; 3 (07) e206004
  CrossrefPubMedGoogle Scholar
• 66 Markwart R, Saito H, Harder T. et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med 2020; 46 (08) 1536-1551
  CrossrefPubMedGoogle Scholar
• 67 World Health Organization. WHO COVID-19 Dashboard. Geneva: 2022
  Google Scholar
• 68 National Center for Health and Statistics. Excess Deaths Associated with COVID-19. Centers for Disease Control and Prevention; 2021
  PubMedGoogle Scholar
• 69 Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA 2020; 324 (15) 1495-1496
  CrossrefPubMedGoogle Scholar
• 70 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062
  CrossrefPubMedGoogle Scholar
• 71 Tong A, Elliott JH, Azevedo LC. et al; COVID-19-Core Outcomes Set (COS) Workshop Investigators. Core outcomes set for trials in people with coronavirus disease 2019. Crit Care Med 2020; 48 (11) 1622-1635
  CrossrefPubMedGoogle Scholar
• 72 Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care – reasons for caution. N Engl J Med 2014; 370 (18) 1673-1676
  CrossrefPubMedGoogle Scholar
• 73 Klompas M, Calandra T, Singer M. Antibiotics for sepsis-finding the equilibrium. JAMA 2018; 320 (14) 1433-1434
  CrossrefPubMedGoogle Scholar
• 74 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
  CrossrefPubMedGoogle Scholar
• 75 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
  CrossrefPubMedGoogle Scholar
• 76 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223): 507-513
  CrossrefPubMedGoogle Scholar
• 77 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 (11) 1061-1069
  CrossrefPubMedGoogle Scholar
• 78 Wang Y, Liao B, Guo Y. et al. Clinical characteristics of patients infected with the novel 2019 coronavirus (SARS-CoV-2) in Guangzhou, China. Open Forum Infect Dis 2020; 7 (06) ofaa187
  CrossrefPubMedGoogle Scholar
• 79 Li X, Xu S, Yu M. et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020; 146 (01) 110-118
  CrossrefPubMedGoogle Scholar
• 80 Richardson S, Hirsch JS, Narasimhan M. et al; The Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323 (20) 2052-2059
  CrossrefPubMedGoogle Scholar
• 81 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med 2020; 382 (24) 2372-2374
  CrossrefPubMedGoogle Scholar
• 82 Yang X, Yu Y, Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (05) 475-481
  CrossrefPubMedGoogle Scholar
• 83 Xu J, Yang X, Yang L. et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care 2020; 24 (01) 394
  CrossrefPubMedGoogle Scholar
• 84 Auld SC, Caridi-Scheible M, Blum JM. et al; And the Emory COVID-19 Quality and Clinical Research Collaborative. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med 2020; 48 (09) e799-e804
  CrossrefPubMedGoogle Scholar
• 85 Feng Y, Ling Y, Bai T. et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 2020; 201 (11) 1380-1388
  CrossrefPubMedGoogle Scholar
• 86 Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M. et al. Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med 2021; 49 (12) 2042-2057
  CrossrefPubMedGoogle Scholar
• 87 Olsen SJA-BE, Azziz-Baumgartner E, Budd AP. et al. Decreased influenza activity during the COVID-19 pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (37) 1305-1309
  CrossrefPubMedGoogle Scholar
• 88 Tan JY, Conceicao EP, Sim XYJ, Wee LEI, Aung MK, Venkatachalam I. Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections. J Hosp Infect 2020; 106 (02) 387-389
  CrossrefPubMedGoogle Scholar
• 89 LeRose J, Sandhu A, Polistico J. et al. The impact of COVID-19 response on central line associated bloodstream infections and blood culture contamination rates at a tertiary care center in Greater Detroit area. Infect Control Hosp Epidemiol 2021; 42 (8): 997-1000
  CrossrefPubMedGoogle Scholar
• 90 Hazel K, Skally M, Glynn E. et al. The other ‘C’: hospital-acquired Clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2022; 43 (4): 540-541
  CrossrefPubMedGoogle Scholar
• 91 Ponce-Alonso M, Saez de la Fuente J, Rincon-Carlavilla A. et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection. Infect Control Hosp Epidemiol 2020; DOI: 10.1017/ice.2020.454.
  CrossrefPubMedGoogle Scholar
• 92 Patel PR, Weiner-Lastinger LM, Dudeck MA. et al. Impact of COVID-19 pandemic on central line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network. Infect Control Hosp Epidemiol 2022; 43 (6): 790-793
  CrossrefPubMedGoogle Scholar
• 93 Halverson T, Mikolajczak A, Mora N, Silkaitis C, Stout S. Impact of COVID-19 on hospital acquired infections. Am J Infect Control 2022; 50 (07) 831-833
  CrossrefPubMedGoogle Scholar
• 94 Evans ME, Simbartl LA, Kralovic SM. et al. Healthcare-associated infections in Veterans Affairs acute and long-term healthcare facilities during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2022; DOI: 10.1017/ice.2022.93.
  CrossrefPubMedGoogle Scholar
• 95 Rosenthal VD, Myatra SN, Divatia JV. et al. The impact of COVID-19 on health care-associated infections in intensive care units in low- and middle-income countries: International Nosocomial Infection Control Consortium (INICC) findings. Int J Infect Dis 2022; 118: 83-88
  CrossrefPubMedGoogle Scholar
• 96 Lastinger LM, Alvarez CR, Kofman A, Konnor RY, Kuhar DT, Nkwata A, Patel PR, Pattabiraman V, Xu SY, Dudeck MA. Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2022; 1-5
  CrossrefPubMedGoogle Scholar
• 97 Weinberger J, Rhee C, Klompas M. Incidence, characteristics, and outcomes of ventilator-associated events during the COVID-19 pandemic. Ann Am Thorac Soc 2022; 19 (01) 82-89
  CrossrefPubMedGoogle Scholar
• 98 Mafham MM, Spata E, Goldacre R. et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 2020; 396 (10248): 381-389
  CrossrefPubMedGoogle Scholar
• 99 Been JV, Burgos Ochoa L, Bertens LCM, Schoenmakers S, Steegers EAP, Reiss IKM. Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study. Lancet Public Health 2020; 5 (11) e604-e611
  CrossrefPubMedGoogle Scholar